Queensland University of Technology a university for the real world
Overview
Queensland University of Technology (QUT) is an established and internationally recognised provider of high-impact biotechnology research. Leading research programs at QUT are located in:
Institute of Health and Biomedical Innovation (IHBI)
A collaborative institute devoted to improving the health of individuals and communities through research innovation. IHBI develops innovative solutions to health issues and also applies these solutions to real world experiences to ensure effective outcomes. Research strengths include:
- Biomedical technologies for wound healing
- Tissue and cell culture applications
- Bioimpedance devices for medical applications
- Cell sheet technology and bone scaffolding
- Diagnostic technologies (gene-based)
- Diagnostic and prognostic biomarkers including biomarkers in hormone-dependent cancer.
Centre for Tropical Crops and Biocommodities
Brings together a unique mix of international expertise in tropical crop biotechnology, industrial chemistry and process engineering to create horizontally integrated research and development from laboratory through pilot plant and field trial to commercial feasibility.
- Industrial enzymes in tobacco
- Banana biofortification and disease resistance
- Sugarcane biomass utilisation
- Syngenta Centre for Sugarcane Biofuels Development
With one of Australia's longest records of successful biotechnology start-ups, QUT has focused its commercialisation and development activities with the establishment of qutbluebox pty ltd (‘bluebox’) as its technology transfer and commercialisation company. Founded in late 2006 to consolidate and develop commercial interactions with external communities of interest (including industry, government and the investment community), bluebox aims to bring the benefits of QUT's research discoveries to the global market via the identification, protection and commercialisation of intellectual property.
bluebox is responsible for managing the intellectual property assets of QUT, and works with the university's staff and students in the management and commercialisation of QUT's innovations through licensing agreements, start-up companies and other industry interactions. In doing so, bluebox builds on QUT's 'real-world' mission of bringing to the community the benefits of teaching, research, technology and service.
Tissue Therapies, Agenix, Panbio and Farmacule Bioindustries are all spin-offs companies from QUT.
Main business focus/
Listing by sector:
- Research Organisation
- Diagnostics
- Infectious Diseases
- Medical Devices
- Drug Discovery & Development
Contact Details
| Contact person | Mr Michael McArdle |
|---|---|
| Job Title | Director, Office of Research |
| Address | GPO Box 2434 |
| City/Suburb | BRISBANE |
| State | Queensland |
| m.mcardle@qut.edu.au | |
| Phone | 07 3138 5376 |
| Fax | 07 3138 1304 |
| Website | http://www.qut.edu.au |
